Willingness-To-Pay of Patients With Chronic Skin Diseases: A Pilot Study

    September 2019 in “ Journal of Investigative Dermatology ”
    J. Lee, R. Lee, Hyun Jeong Ju, Myungshin Kim, J. Kim, Chul Hwan Bang, Jae Hoon Han, J. Lee, Young Sup Woo, Jung Min Bae
    TLDR Vitiligo patients are willing to pay the most for treatment, regardless of disease severity.
    This pilot study evaluated the quality of life (QoL) and willingness-to-pay (WTP) in 124 patients with chronic skin diseases, including alopecia areata (AA), atopic dermatitis (AD), chronic urticaria (CU), psoriasis, and vitiligo. Using the Dermatology Life Quality Index (DLQI) and WTP questionnaires, the study found that AD patients had the highest median DLQI score (13), while vitiligo patients had the highest median monthly WTP for disease control ($185) and one-time WTP for disease cure ($1891). Interestingly, vitiligo patients exhibited high WTP regardless of their body surface area (BSA) involvement, suggesting that DLQI may not be a critical indicator of treatment decisions.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 229 results

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 8 months ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community I think I’ve finally found the reason for my hair loss

      in Chat  98 upvotes 2 weeks ago
      The user experienced hair loss since 2019 and tried finasteride, dutasteride, RU58841, and ketoconazole shampoo without success. A scalp biopsy showed scarring and inflammation from folliculitis, indicating chronic inflammation was affecting treatment effectiveness.
      Physio-metabolic method of treating androgenic alopecia. Cold receptors. The relationship between DHT, cold receptors, minoxidil and antiandrogens

      community Physio-metabolic method of treating androgenic alopecia. Cold receptors. The relationship between DHT, cold receptors, minoxidil and antiandrogens

      in Research  411 upvotes 2 weeks ago
      Treating androgenic alopecia with minoxidil, finasteride, and antiandrogens, alongside exercise, cryotherapy, and natural substances to stimulate cold receptors for better hair growth. The method focuses on enhancing treatment effectiveness by considering environmental and behavioral factors and the role of cold receptors and muscle stress.

      community Sunlight: Does it Stimulate Hair Growth or Hair Loss?

      in Research/Science  61 upvotes 8 months ago
      The conversation discusses whether sunlight exposure affects hair growth or loss, with mixed anecdotes and theories but no clear consensus. Some suggest moderate sunlight can benefit hair by providing vitamin D, while others doubt its effectiveness compared to treatments like Minoxidil or finasteride.

    Similar Research

    5 / 1000+ results